First Trust SMID Capital Strength ETF (FSCS)

In 8 Minutes - Watch & Learn

Growth isn't only about launching new products.
Sometimes it's about building a stronger corporate foundation first.
$TDTH believes its capital structure initiatives will create a more streamlined and institutionally focused company as it completes the transition to direct Nasdaq ordin

Nice info my man. With those revenues, and future announcements of government contracts... Oh billy, we have a golden winner here.

......AGREED, bobbie...........gonna be a nasty re-set of most economies and the USA might get hit hardest...............MEGA TECH and A-I are gonna lead the collapse, imo................

.......banks will fall, but not as far nor as fast, imo...............slow, painful SLIDE........

Despite your insinuations, I do understand that there are lots of costs/expenses in developing anything in the medical field, such as drugs and other treatments (like medical devices).

I was just responding to a poster who was wondering about the price behavior of RDGL after IDE appro

Yes sirree that NEWS got the investors excited for sure. They are pounding the ask, buying up the floating shares... LMAO

I feel your pain. Welcome to stage one skepticism.

JOBY zone under $7.75

True… for majority of big pharmas bc they dont want to carry the burden and work to get human approval trials themselves. And then There are always other pharmas which have been following rdgl’s progresses and preliminary results in India and they may be convinced enough to propose an offer to buy o

Dave in Indiana is buying

Femike, thanks for taking time to contradict his AI generated garbage. 🙏🏾

$RITE Know what you own.As a shareholder/supporter of Mineralrite,I can't stress this enough everyone DYODD .Official SEC filings always beats message board noise everytime.$RITE Place $RITE Time 💯💯💪💪💰💰

All of that and no bid

We have a seller, this 015 / 200 ma support area needs to hold or 01 is a possibility

Wow, that spread is a little rough. Just got about 100k at .0151

awesome news.

stock should start moving on up today.

it is oversold and extremely undervalued.



this should be trading around .10 in a week or so.

$DOSE (CCE) $RDTCF Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
https://www.newsfilecorp.com/release/304185/Rapid-Dose-Therapeutics-Extends-Strategic-Collaboration-with-Global-Nicotine-Leader-and-Initiating-

Premier Graphene Inc. (BIEI) makes Down Payment for the Production of a Second SEDENA Contract
Having Completed Delivery on the First Government Contract, Premier Wasted No Time in Preceding with yet Another Contract with More to Come

MEXICO CITY, July 07, 2026 (GLOBE NEWSWIRE)

Premier Graphene Inc. (BIEI) makes Down Payment for the Production of a Second SEDENA Contract
Having Completed Delivery on the First Government Contract, Premier Wasted No Time in Preceding with yet Another Contract with More to Come

MEXICO CITY, July 07, 2026 (GLOBE NEWSWIRE)

Whatever happened to Dshade saying $20 no problem because it's gonna be MASSIVE?? That's why he's in hiding. LMAO

TERS Tersis Technologies Appoints Cynthia Maloney as Vice President of Strategic Grants & Public-Private Partnerships
By Newsfile Corp. for Newsfile Corp

Brooksville, Florida--(Newsfile Corp. - July 7, 2026) - Tersis Technologies, Inc. (OTCID: TERS), a clean technology company

DTIL

https://x.com/saltwaterstocks/status/2074533350761455979?s=46

$DOSE (CCE) $RDTCF Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
https://www.newsfilecorp.com/release/304185/Rapid-Dose-Therapeutics-Extends-Strategic-Collaboration-with-Global-Nicotine-Leader-and-Initiating-

Tersis Technologies Appoints Cynthia Maloney as Vice President of Strategic Grants & Public-Private Partnerships
By Newsfile Corp. for Newsfile Corp

Brooksville, Florida--(Newsfile Corp. - July 7, 2026) - Tersis Technologies, Inc. (OTCID: TERS), a clean technology company focus